StockData

Seaport Therapeutics, Inc. (SPTX) stock

SPTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026
$18.17−0.95 (-4.97%)

Close on Nov 17, 2026Market cap $972.65MP/E –Yield –

Seaport Therapeutics cash

Cash and short-term investments held at the end of each period.

Seaport Therapeutics's cash was $290.43M at Sep 30, 2026. For fiscal 2025 it was $215.98M.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$215.98M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$290.43M–
Q2 FY2026Jun 30, 2026$273.31M–
Q1 FY2026Mar 31, 2026$182.61M–
Q4 FY2025Dec 31, 2025$215.98M–

More Seaport Therapeutics figures

See a number that looks wrong?